Next Quarterly Earnings
Friday, October 30, 2026
CW 44
In 17 days
Confirmed by the company
Date confirmed from the official Chinese exchange disclosure timetable.
Shenzhen Hepalink Pharmaceutical Group A
Shenzhen Hepalink Pharmaceutical Group A is a leading global biotechnology company based in China. It specializes in the development and production of heparin active ingredients and innovative drugs for oncology, autoimmune diseases, and complex therapies.
Frequently asked questions
When will Shenzhen Hepalink Pharmaceutical Group A report its next quarterly earnings?
Shenzhen Hepalink Pharmaceutical Group A is scheduled to report its next quarterly earnings on 10/30/2026.
When did Shenzhen Hepalink Pharmaceutical Group A last report quarterly earnings?
Shenzhen Hepalink Pharmaceutical Group A last reported quarterly earnings on 8/28/2026 (Q2 2026). Earnings per share (EPS) came in at 0.06 CNY.
How does Shenzhen Hepalink Pharmaceutical Group A stock react to earnings?
Across its last 3 earnings reports, Shenzhen Hepalink Pharmaceutical Group A stock moved by ±0.9% on average the following day. The largest reaction was -1.4% on 08/28/2026; 1 of 3 reactions were positive.
How do I add the Shenzhen Hepalink Pharmaceutical Group A earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
In the earnings calendar
Earnings statistics
Stock reaction to earnings
±0.9%
Avg. next-day move
-1.4%
Largest move (08/28/2026)
33.3%
Share of positive reactions
±3.8%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Shenzhen Hepalink Pharmaceutical Group A
Country
🇨🇳
More Financial Information